Literature DB >> 9136851

Fatal acute fulminant liver failure due to clozapine: a case report and review of clozapine-induced hepatotoxicity.

B Macfarlane1, S Davies, K Mannan, R Sarsam, D Pariente, J Dooley.   

Abstract

Clozapine-induced hepatotoxicity is not well known and is usually of no clinical significance. This report describes fatal acute fulminant liver failure caused by clozapine in a 39-year-old man with chronic paranoid schizophrenia. The hepatotoxicity of clozapine is reviewed. Asymptomatic elevation of transaminase levels is observed most commonly, affecting between 30% and 50% of patients. Icteric hepatitis is uncommon, noted in 84 of 136,000 patients (0.06%). Fatal acute fulminant hepatitis has been documented in 2 patients (0.001%). The mechanism of clozapine hepatotoxicity is unknown. Although serious toxicity is rare, prescribers of clozapine should be aware of the hepatotoxic potential.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9136851     DOI: 10.1016/s0016-5085(97)70054-4

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

1.  Comment on "Eosinophilic gastroenteritis: clinical experience with 15 patients".

Authors:  Peter-J Kerr
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

2.  Re: Recent case report of clozapine-induced acute hepatic failure.

Authors:  Anna C Chaplin; Michael A Curley; Ian R Wanless
Journal:  Can J Gastroenterol       Date:  2010-12       Impact factor: 3.522

Review 3.  Fatalities associated with therapeutic use and overdose of atypical antipsychotics.

Authors:  Adam Trenton; Glenn Currier; Frank Zwemer
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

4.  Clozapine-induced fatal fulminant hepatic failure: a case report.

Authors:  Albert Chang; Darin S Krygier; Nazira Chatur; Eric M Yoshida
Journal:  Can J Gastroenterol       Date:  2009-05       Impact factor: 3.522

Review 5.  Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions.

Authors:  Mahmoud Slim; Inmaculada Medina-Caliz; Andres Gonzalez-Jimenez; M Rosario Cabello; Fermin Mayoral-Cleries; M Isabel Lucena; Raul J Andrade
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

Review 6.  Monitoring the safe use of clozapine: a consensus view from Victoria, Australia.

Authors:  Michael Berk; Joanna Fitzsimons; Timothy Lambert; Christos Pantelis; Jayashri Kulkarni; David Castle; Elizabeth W Ryan; Sean Jespersen; Pat McGorry; Gregor Berger; Bill Kuluris; Tom Callaly; Seetal Dodd
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

7.  Eosinophilia, pleural effusion, hepatitis, and jaundice occurring early in clozapine treatment.

Authors:  Shi Hyun Kang; Jong-Il Lee
Journal:  Clin Psychopharmacol Neurosci       Date:  2013-08-26       Impact factor: 2.582

8.  Clozapine-induced liver injury and pleural effusion.

Authors:  Joseph P M Kane; Francis A O'Neill
Journal:  Ment Illn       Date:  2014-09-08

9.  Drug-Induced Liver Injury during Antidepressant Treatment: Results of AMSP, a Drug Surveillance Program.

Authors:  Michaela-Elena Friedrich; Elena Akimova; Wolfgang Huf; Anastasios Konstantinidis; Konstantinos Papageorgiou; Dietmar Winkler; Sermin Toto; Waldemar Greil; Renate Grohmann; Siegfried Kasper
Journal:  Int J Neuropsychopharmacol       Date:  2016-04-20       Impact factor: 5.176

10.  Hepatotoxicity induced by clozapine: a case report and review of literature.

Authors:  Ana Isabel Wu Chou; Mong-Liang Lu; Winston W Shen
Journal:  Neuropsychiatr Dis Treat       Date:  2014-08-26       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.